Table 2.
Medication and laboratory testing details.
| n or n (%) or median [range] | |
|---|---|
| Patients | 50 |
| Heparin | - |
| Courses | 55 |
| Indication for heparin | - |
| Thrombosis | 27 (49) |
| Postoperative cardiac surgery | 22 (40) |
| Thrombosis and postoperative cardiac surgery | 5 (9) |
| Postoperative noncardiac surgery | 1 (2) |
| Infusion rate | - |
| 2 hours before AT supplementation | 32 [0-50] |
| 24 hours after AT supplementation | 32 [0-54] |
| 48 hours after AT supplementation | 32 [0-54] |
| Antithrombin | - |
| Treatments | 61 |
| Doses | 75 |
| Baseline activity level, (%) | 37 [18-61] |
| Target activity level, (%) | 99 [47-150] |
| Dose, units per kg | 41 [9-84] |
| Laboratory Tests | |
| Pre-AT PTT level (seconds) | 62.1 [33.2-200] |
| Pre-AT anti-FXa level (units/mL) | 0.1 [0.1-0.32] |
AT, antithrombin; FXa, activated factor X; PTT, partial thromboplastin time.